The University of Pittsburgh Graduate School of Public Health is proud to launch Cura Zika, an international alliance to perform much-needed research addressing the Zika epidemic by uniting Pitt biomedical scientists and their Brazilian collaborators.
Zika is a mosquito-borne and sexually transmitted virus which causes microcephaly in infants born to mothers infected with it. It is also associated with increased risk of Guillain-Barre syndrome and other neurological disorders in people who contract it. The virus is widespread in Southern and Central America and has a likelihood of gaining sustained transmission in the Southern U.S.
Cura Zika builds on Pitt Public Health’s long-standing collaboration with FIOCRUZ , the Brazilian Ministry of Health’s Fundação Oswaldo Cruz Foundation, the most prominent science and technology health institution in Latin America. Cura Zika—which means ‘Cure Zika’ in both Portuguese and Spanish—will provide quick access funding to scientists performing time-sensitive research on the virus. This support is designed to move early-stage innovative research ideas into larger studies in an accelerated manner.
Find out more about the research currently under way at this Pitt Public Health event: Cura Zika Pilot Research Grant Presentations.
Help address the Zika epidemic by providing critical, quick-access funding to scientists with innovative, early-stage research ideas.
Zika and travel: Marques tells you what you need to know
The Zika virus is still a threat. Here's what Marques, other experts know
Marques finds that previous exposure to Dengue Fever protects against Zika
View more Zika news
Send questions about the Cura Zika initiative, an international alliance to perform much-needed research addressing the Zika epidemic, to CuraZika@pitt.edu.
Allison Hydzik,manager of media relations email@example.com 412-647-9975
Ernesto T. A. Marques
Scientific advisors Fernando Bozza Lee Harrison Cecilia Lo Celina Martelli Yoel Sadovsky